AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells

Srdan Verstovsek, Mirna Golemovic, Hagop Kantarjian, Tashi Manshouri, Zeev Estrov, Paul Manley, Tong Sun, Ralph B. Arlinghaus, Leila Alland, Margaret Dugan, Jorge Cortes, Francis Giles, Miloslav Beran*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology